ストックスクリーナーアプリを入手
6.75
2.88%
-0.20
前日終値:
$6.95
開ける：
$7.0248
24時間の取引高:
4,427
Relative Volume:
0.08
時価総額：
$41.12M
収益：
$5.75M
当期純損益:
$-38.96M
株価収益率:
-0.5413
EPS:
-12.47
ネットキャッシュフロー:
$-32.63M
1週間 パフォーマンス:
-5.86%
1か月 パフォーマンス:
-13.02%
6か月 パフォーマンス:
+14.21%
1年 パフォーマンス:
-11.76%
1日の値動き範囲:
$6.73
$7.0248
1週間の範囲:
$6.49
$7.13
52週間の値動き範囲:
$4.21
$11.20
Kala Bio Inc Stock (KALA) Company Profile
KALA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
6.75 | 41.12M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-03-30 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-09-14 | ダウングレード | Jefferies | Buy → Hold |
| 2020-07-23 | 開始されました | Northland Capital | Outperform |
| 2020-06-01 | 再開されました | Oppenheimer | Outperform |
| 2020-05-27 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-09 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | 開始されました | Jefferies | Buy |
すべてを表示
Kala Bio Inc (KALA) 最新ニュース
Kala Bio appoints new interim CEO amid leadership shuffle - MSN
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference - TradingView
BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million - The Manila Times
What Will KALA BIO Reveal at the TD Cowen Healthcare Conference Next Week? - StockTitan
Kala Bio Stock Sinks On CEO Exit, But Retail Feels It’s An Overreaction - MSN
Precision Bio stock gains on Hep B drug data (DTIL:NASDAQ) - Seeking Alpha
Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company's Growth - The Manila Times
Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company’s Growth - GlobeNewswire
Major Leadership Shake-up: Pharma Veteran Takes Helm at Inhibikase with $110M War Chest - StockTitan
KALA BIO's (KALA) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Kala Bio Inc (NASDAQ: KALA) Has Been Trading Down. What Are The Prospects For The Future? - Stocks Register
KALA BIO says CEO Mark Iwicki resigns - MSN
Cabaletta Bio to Present at Guggenheim’s SMID Cap Biotech Conference - MSN
Lee joins Lycia as CMO - BioCentury
Kala Bio announces CEO departure, appoints interim leader By Investing.com - Investing.com Nigeria
Kala Bio appoints new interim CEO amid leadership shuffle By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Chefs' Warehouse, Aptose Biosciences, Electromed - TradingView
Stock Market Today: Dow Jones tumbles 400 points as US inflation surges to 3%, S&P 500 and Nasdaq also slide amid Fed rate cut concerns - MSN
Stock Market Today: Dow Jones tumbles 400 points as US inflation surges to 3%, S&P 500 and Nasdaq also sli - The Economic Times
Stock market news: Spire Global -52.49%, Atomera -38.61% among biggest losers during midday trading - Business Upturn
Dow Drops More Than 400 Points After CPI Data - Schaeffers Research
Kala Bio Chief Executive Mark Iwicki Resigns; Shares Fall -February 12, 2025 at 11:59 am EST - Marketscreener.com
Kala Bio tumbles after CEO resignation - TradingView
Stock market today: Spire Global -50.98%, KALA BIO -32.54% among biggest losers in early trading - Business Upturn
Wall Street Today: Dow Jones drops 400 points as US Inflation rises 50 bps to 3% YoY, dimming hopes for Fed rate cuts - Mint
KALA BIO, Inc. Announces Chief Executive Officer Changes -February 12, 2025 at 08:00 am EST - Marketscreener.com
Kala Bio announces CEO departure, appoints interim leader - Investing.com
KALA BIO Announces Chief Executive Officer Transition - The Manila Times
Leadership Shake-Up at KALA BIO: New CEO Takes Helm Before Crucial Phase 2b Eye Treatment Results - StockTitan
KALA BIO (NASDAQ:KALA) and Prothena (NASDAQ:PRTA) Financial Survey - Defense World
Avis Budget CEO Joe Ferraro to Step Down, Brian Choi Named Successor - MSN
Katoro Gold announces general meeting and office move - MSN
Kala Pharma Catches Investors' Eye, Stock Hits New High - RTTNews
Short Interest in KALA BIO, Inc. (NASDAQ:KALA) Rises By 19.1% - MarketBeat
Guardian Revival Names CEO - MSN
KALA stock soars to 52-week high, reaching $8.81 - MSN
KALA stock soars to 52-week high, reaching $8.81 By Investing.com - Investing.com Australia
ED Attaches ₹79.78 Crore Assets In Sharon Bio-Medicine’s ₹220 Crore Bank Fraud Case - Free Press Journal
Atara stock extends losses on FDA clinical hold (ATRA:NASDAQ) - Seeking Alpha
Ramesh Lal Kala , IND candidate bio : Assets , Total Income , Liabilities , Criminal Cases and other details. - The Hindu
KALA BIO Announces $10.75 Million Private Placement Agreement - WilmerHale
Kala Bio executive Todd Bazemore sells $15,206 in stock By Investing.com - Investing.com Australia
Kala Bio Inc (KALA) 財務データ
収益
当期純利益
現金流量
EPS
1.39%
0.55%
大文字化:
|
ボリューム (24 時間):